Trial intelligence / Profile preview

Clobetasol vs Dexamethasone for Oral Chronic Graft-versus-host Disease

NCT01699412Phase 3Completed

Sponsor
Grupo de Estudos Multicêntricos em Onco-Hematologia
Start
Aug 2008
Primary completion
Jul 2012
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of clobetasol, dexamethasone in graft-versus-host disease (GVHD), sponsored by Grupo de Estudos Multicêntricos em Onco-Hematologia. Started Aug 2008; status: completed.

02

Drugs

clobetasoldexamethasone
03

Conditions

graft-versus-host disease (GVHD)

Beyond the preview

Go deeper on NCT01699412.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01699412.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call